Company intelligence / Profile preview
Vicebio
London, England, United Kingdomvicebio.com ↗
- Ownership
- Private
- Development stage
- Clinical
01
Overview
Vicebio has initiated a Phase I clinical trial for its lead bivalent vaccine candidate VXB‑241 targeting RSV and hMPV. The company’s proprietary Molecular Clamp technology stabilizes viral antigens in their prefusion state to elicit strong immune responses. Early preclinical and initial clinical data are described as promising for broad protection against multiple respiratory viruses. The company recently raised $100 million Series B financing to accelerate development of its multivalent vaccine pipeline.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Recombinant protein vaccines (using stabilized viral glycoproteins)Multivalent vaccines
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Exclusive license with UniQuest/The University of Queensland for the Molecular Clamp technology; no major pharma partnerships disclosed yet but investors include leading healthcare funds.
Beyond the preview
Go deeper on Vicebio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vicebio.